MedTrace Logo

anti_endometrial Antibodies in Endometriosis

NCT05851352 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-05-09

No results posted yet for this study

Summary

The aims of this study is to asses the predictive value of serum anti\_endometrial antibodies in prediction of implantation rate in patient with endometriosis who undergoing intracytoplasmic sperm injection cycles.

Conditions

  • Anti-endometrial Antibodies

Interventions

DIAGNOSTIC_TEST

serum anti-endometrial antibodies

\- Take blood samples from patients to measure anti-endometrial antibody concentrations in the serum of women with endometriosis using human Endometrium Antibody, EMAb ELISA Kit .This assay employs the qualitative enzyme immunoassay technique

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Abdelrahman A Elsayed, professor · South Valley University

  • mostafa M Khodry, lecturer · South Valley University

  • Radwa M Fahmy, lecturer · Cairo University

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-06-01
Completion
2023-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05851352 on ClinicalTrials.gov